Put companies on watchlist
Semperit AG Holding
ISIN: AT0000785555
WKN: 870378
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Semperit AG Holding · ISIN: AT0000785555 · EQS - adhoc news (52 News)
Country: Austria · Primary market: Austria · EQS NID: 1572419
01 March 2023 05:31PM

Semperit AG Holding: Executive Board proposes basic dividend of EUR 1.50 per share plus a conditional additional dividend of EUR 2.00 to EUR 3.50 per share for 2022


EQS-Ad-hoc: Semperit AG Holding / Key word(s): Dividend
Semperit AG Holding: Executive Board proposes basic dividend of EUR 1.50 per share plus a conditional additional dividend of EUR 2.00 to EUR 3.50 per share for 2022

01-March-2023 / 17:31 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad-hoc information

Semperit Executive Board proposes basic dividend of EUR 1.50 per share plus a conditional additional dividend of EUR 2.00 to EUR 3.50 per share for 2022

Vienna, Austria, 1 March 2023 – The Executive Board of Semperit AG Holding has decided to propose to the Annual General Meeting a basic dividend of EUR 1.50 per share as well as a conditional additional dividend of EUR 2.00 to EUR 3.50 per share for the 2022 financial year. This results in a total dividend proposal of a maximum of EUR 5.00 per share for the 2022 financial year (previous year: EUR 1.50 per share). The basic dividend will be paid out on 3 May 2023.

The entitlement to the additional dividend depends on the sale of the medical business (Sempermed; production of examination gloves including sales organisation first) by 30 September 2023. The closing of the sale of the medical business is, in particular, still subject to the approval of the foreign direct investment control and competition authorities.

The exact amount of the additional dividend proposal depends on the economic outlook and on organic and inorganic growth projects becoming more substantiated. The Executive Board will announce a more concrete additional dividend proposal in due time before the Annual General Meeting of Semperit AG Holding on 25 April 2023.

This one-time deviation from the dividend policy of Semperit AG Holding should be seen in light of the successful separation from the medical business.


 

For questions, please contact:
 

Alexander Kleedorfer 

Director Group Brand Management (interim),
Corporate Spokesperson 

+43 676 8715 8464
alexander.kleedorfer@semperitgroup.com
  Judit Helenyi
 
Director Investor Relations
 
 
+43 676 8715 8310
judit.helenyi@semperitgroup.com
 

 

www.semperitgroup.com

www.linkedin.com/company/semperit-ag

 


01-March-2023 CET/CEST News transmitted by EQS Group AG. www.eqs.com


Language: English
Company: Semperit AG Holding
Am Belvedere 10
1100 Wien
Austria
Phone: +43 1 79 777-310
Fax: +43 1 79 777-602
E-mail: judit.helenyi@semperitgroup.com
Internet: www.semperitgroup.com
ISIN: AT0000785555
Listed: Vienna Stock Exchange (Official Market)
EQS News ID: 1572419

 
End of Announcement EQS News Service

1572419  01-March-2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1572419&application_name=news&site_id=boersengefluester_html
Visual performance / price development - Semperit AG Holding
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.